Region of Central and Eastern Europe

  • Population: 85 million
  • Total GDP: 1400 billion USD
  • Volume of pharmaceutical market: USD > 6 billion (2010)
  • Estimated pharmaceutical market by the year 2014: USD 11 billion
Pharmaceutical market in CEE region, despite negative global economic development over the last years, is still growing faster than most of Western Europe.
This is challenging opportunity for pharmaceutical companies.
However, in contrary to the Western Europe, CEE region is very heterogeneous in many aspects: economical, political, cultural etc.
All these markets (Czech Republic, Slovakia, Hungary, Slovenia, Croatia, Bosnia, Serbia, Romania, Bulgaria, Kosovo, Montenegro, Macedonia) have their own specific rules and habits. Being familiar  with these complex mechanisms is the key factor for success. Thus, CEEMED was created to satisfy this growing need of expertise in CEE region.